INVESTIGATION OF THE FREQUENCY OF MEFV GENE MUTATIONS IN PATIENTS WITH FAMILIAL OLIVE FEVER
![](https://ojsdergi.com/ojsicons/gor.png)
![](https://ojsdergi.com/ojsicons/pdf.png)
DOI:
https://doi.org/10.5281/zenodo.10459605Abstract
Background: The aim of this study was to investigate the types and distribution of MEFV gene mutations in patients with Familial Mediterranean Fever (FMF) who were followed up in the Rheumatology outpatient clinics of Kartal Dr. Lütfi Kırdar City Hospital.
Method: A total of 282 unrelated patients who were admitted to rheumatology outpatient clinics between 2020 and 2022, diagnosed with FMF according to Tel-Hashomer criteria or newly diagnosed during this period were included in the study. The data of the patients were retrospectively screened through the hospital database. MEFV gene mutations of the patients were identified and recorded.
Results: As a result of the study, only 26.1% of the patients were found to carry homozygous mutations. There was no significant difference between mutation type and gender, age at diagnosis and symptoms at the time of diagnosis. There was no significant difference between the number of attacks in the last year and mutation type. The most common mutations found in FMF patients were M694V, R202Q, M680I, V726A, E148Q and K695R in order of frequency.
Conclusion: The most common mutations found in patients with FMF are M694V, R202Q, M680I, V726A, E148Q and K695R. However, no correlation has been shown between mutations and clinical findings.
References
Bakkalloğlu A. Familial Mediterranean Fever. Pediatr Nephrol.2003; 18:853-9.
Erden G, Bal C, Torun OG, Uguz N, Yıldırımkaya M. Evaluating the Frequency of MEFV Gene in a Group of Patients with a Pre-diagnosis of Familiar Mediterranean Fever. Turk Hij Den Biyol Derg. 2008; 65(1): 1-5
Cattan D, Delpech M. Fievre mediterraneenne familiale (maladie periodique). Hepato Gastro 1996;3:369-76
The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90(4):797-807.
The French FMF Consortium. A candidate gene for familial Mediterranean fever. NatGenet 1997; 17: 25-31
Livneh A, Langevitz P, Zemer D et al. The changing face of Familial Mediterranean Fever. Semin Arthritis Rheum 1996;26: 612-27.
Medlej-Hashim M, Delague V, Choueri E, et al. Amyloidosis in Familial Mediterranean Fever patients:correlation with MEFV genotype and SAAI and MICA polymorphisims effects. BMC Med Genet 2004;5:1-6
Duşunsel R, Dursun I, Gündüz Z, Poyrazoğlu MH, Gürgöze MK, Dundar M. Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr Int 2008; 50: 208–212.
Yilmaz E, Dinçel N, Sözeri B, Ozdemir K, Bulut IK, Berdeli A, Mir MS. Familial Mediterranean fever in children from the Aegean region of Turkey: gene mutation frequencies and phenotype-genotype correlation. Turk J Med Sci. 2015;45(6): 1198-206
Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 2005; 84: 1–11.
Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, Kartalis, G, Speletas M, Ritis K. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 2007; 71: 458–467.
Yeşilada, E., Savacı, S., Yüksel, Ş., Gülbay, G., Otlu, G., &Kaygusuzoğlu, E. (2005). Ailesel akdeniz ateşi (fmf) düşünülen olgularda MEFV gen mutasyonları. Journal of Turgut Ozal Medical Center, 12(4), 235-238.
Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553555.
Solak M, Yildiz H, Koken R, Erdogan M, Eser B, Sen T, Evirgen N, Erdem S, Arikan E. Analysis of familial Mediterranean fever gene mutations in 202 patients with familial Mediterranean fever. Genet Test 2008; 12: 341–344.
Berdeli A, Mir S, Nalbantoglu S, Kutukculer N, Sozeri B, Kabasakal Y, Cam S, Solak M. Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a “heterozygote advantage” in Turkey? Genet Test MolBiomarkers 2011; 15: 475–482.
![](https://onehealthjournal.com/public/journals/1/submission_21_21_coverImage_en_US.jpg)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of One Health Research
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.